Evaluation of lysophosphatidic acid in vaginal fluid as a biomarker for ovarian cancer: A pilot study

There remains a need to differentiate between women with a benign or a malignant adnexal mass prior to surgery. As part of an ongoing evaluation of vaginal fluid compounds as potential tumor biomarkers we evaluated whether vaginal lysophosphatidic acid (LPA) predicted the subsequent diagnosis of a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Minis, Evelyn, Holcomb, Kevin, Sisti, Giovanni, Nasioudis, Dimitrios, Kanninen, Tomi T., Athanasiou, Aikaterini, Frey, Melissa K., Chapman-Davis, Eloise, Caputo, Thomas A., Witkin, Steven S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Gynaecology: Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683972/
https://www.ncbi.nlm.nih.gov/pubmed/31396597
http://dx.doi.org/10.1016/j.eurox.2019.100012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683972/
https://www.ncbi.nlm.nih.gov/pubmed/31396597
http://dx.doi.org/10.1016/j.eurox.2019.100012

Ejemplares similares